ВЛИЯНИЕ МЕТАБОЛИЧЕСКИХ НАРУШЕНИЙ НА ТЕЧЕНИЕ ОСТЕОАРТРОЗА
- Авторы: Артёменко Н.А.1, Тер-Ананьянц ЕА1, Машталова ОГ1
-
Учреждения:
- КБ №1 ФГУ ЮОМЦ ФМБА России
- Выпуск: Том 2, № 1 (2011)
- Страницы: 57-62
- Раздел: Статьи
- URL: https://journal-vniispk.ru/clinpractice/article/view/8197
- DOI: https://doi.org/10.17816/clinpract2157-62
- ID: 8197
Цитировать
Полный текст
Аннотация
Ключевые слова
Полный текст
Открыть статью на сайте журналаОб авторах
Наталья Алексеевна Артёменко
КБ №1 ФГУ ЮОМЦ ФМБА России
Email: n.artemenko@inbox.ru
врач-ревматолог, к.м.н. КБ №1 ФГУ ЮОМЦ ФМБА России
Е А Тер-Ананьянц
КБ №1 ФГУ ЮОМЦ ФМБА России
О Г Машталова
КБ №1 ФГУ ЮОМЦ ФМБА России
Список литературы
- Fan Z., Bau B., Yang H. et al. Freshly isolated osteoarthritic chondrocytes are catabolically more active than normal chondrocytes, but less responsive to catabolic stimulation with interleukin1beta //Arthritis Rheum. 2005. Vol. 52 (1). P. 136-143.
- Yoo S.A., Park B.H., Yoon H.J. et al. Calcineurin modulates the catabolic and anabolic activity of chondrocytes and participates in the progression of experimental osteoarthritis // Arthritis Rheum. 2007. Vol. 56 (7). Р. 2299-2311.
- Dandona P., Aljada A.,Chaudhury A. et al. Metabolic Syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation // Circulation. 2005. Vol. 111 (11). Р. 1448-1454.
- Grundy S.M. Inflammation, hypertension, and metabolic syndrome // JAMA. 2003. Vol. 290 (22). P. 3000-3002.
- Wellen K.E., Hotamisligil G.S. Inflamation, stress, and diabetes // J. Clin. Invest. 2005. Vol. 115 (5). P. 1111-1119.
- Altman RD. Measurement of structure (disease) modification in osteoarthritis // Osteoarthritis Cartilage. 2004. Vol. 12. Suppl. A. Р. S69-S76.
- Bloomgarden А. Inflammation and insulin resistance // Diabetes Care. 2003. Vol. 26 (5). Р. 1619-1623.
- Зубарев А.В. Диагностический ультразвук. Костномышечная система. М.: ООО "Фирма Стром"., 2002 136 с.
- McWilliams D.E., Reehana G., Carolyn B. et al. Cartilage oligomezic matrix protein and aggrecan in synovial fluid from patients with osteoarthritis: markers of local or systemic characteristics? // Rheumatology. 2004. Vol. 43. Suppl. 2. P. 68.
- Hunter D.J., Niu J., Zhang Y. et al. Knee height, knee pain, and knee osteoarthritis: the Beijing Osteoarthritis Study //Arthritis Rheum. 2005. Vol. 52 (5). P. 1418-1423.
- Cicuttini F.M., Teichtahl A.J., Wluka A.E. et al. The relationship between body composition and knee cartilage volume in healthy, middleaged subjects. //Arthritis Rheumatism. 2005. Vol. 52 (2). P. 461-467.
- Putz D.M., Goldner W.S., Bar R.S. et al. Adiponectin and Creactive protein in obesity, type 2 diabetes, and monodrug therapy // Metabolism. 2004. Vol. 53 (11). Р. 1454-1461.
- Kumar N., Marshall N.J., Neely D. et al. CRP levels are raised in patients with longstanding osteoarthritis when compared with normal controls // Rheumatology. 2004. Vol. 43. Suppl. 2. P. 69.
- Belo J.N., Berger M.Y., Reijman M. et al. Prognostic factors of progression of osteoarhtritis of the knee – a systemic factors and disease stage // Ann. Rheam. Dis. Ann. Eur. Congr. of Rheumatology EULAR 2005. Abstracts. Vol.64. Suppl. 111. P. 479.
- Agarwal S., Deschner J., Long P. et al. Role of NFkb transcription factors in antiinflammatory and proinflammatory actions of mechanical signals //Arthritis Rheum. 2004. Vol. 50 (11). P. 3541-3548.
- Aronson D., Bartha P., Zinder O. et al. Obesity is the major determinant of elevated Creactive protein in subjects with the metabolic syndrome // Int. J. Obes. Relat. Metab. Disord. 2004. Vol. 28 (5). P. 674-679.
- Saxne T., Lindell M., MDnsson B et al. Inflammation is a feature of the disease process in early knee joint osteoarthritis // Rheumatology (Oxford). 2003. Vol. 42 (7). P. 903-904.
- Ridker P.M., Wilson P.W., Grundy S.M. Should Creactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? // Circulation. 2004. Vol. 109 (23). Р. 2818-2825.
- Sharma L. Local factors in osteoarthritis. // Curr. Opin. Rheumatol. 2001. Vol. 13 (5). P. Р. 441-446.
- Алексеева Л.И., Зайцева Е.М. Субхондральная кость при остеоартрозе: новые возможности терапии // РМЖ. 2004. Т. 12, № 20 С. 1133-1136.
- Bastard J.P., Maachi M., Van Nhieu J.T. et al, Adipose tissue IL6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro // J. Clin. Endocrinol. Metab. 2002. Vol. 87 (5). P. 2084-2089.
- Behre C.J., Fagerberg B., HultJn L.M., Hulthe J. The reciprocal association of adipocytokines with insulin resistance and Creactive protein in clinically healthy men // Metabolism. 2005. Vol. 54 (4). Р. 439-444.
- Andersson M.L., Saxne T., Petersson I.F. Creactive protein as a marker of developing knee joint osteoarthritis – A 12 year followup // Arthritis Rheum. 2007. Vol. 56 (9). P. 1461-1478.
- Yeh E.T. CRP as a mediator of disease // Circulation. 2004. Vol. 109 (21 Suppl. 1): II-114.
- Brandt KD., Lohmander S., Doherty M. Pathogenesis of osteoarthritis. Introduction: The concept of osteoarthritis as failure of the diarthrodial joint / In K.D. Brandt, M. Doherty, S. Lohmander (eds.), Osteoarthritis, Second Edition. Oxford: Oxford University Press 2003: Р. 69-71.
- Anan F., Takahashi N., Nakagawa M. et al. Highsensivity Creactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients // Metabolism. 2005. Vol. 54 (4). Р. 552-558.
Дополнительные файлы
